Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than rivaroxaban in patients with atrial fibrillation at moderate-to-high risk ...
Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for ...
Milvexian is in three late-stage studies in AF, stroke, and acute coronary syndromes (ACS), while abelacimab is in the phase 3 LILAC-TIMI 76 in patients with AF deemed unsuitable for current OAC ...
John Friend, MD, CEO of Kazia Therapeutics added, "The novelty of the science that Professor Rao has proposed with this dual ...
The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the ...
Lupus, or systemic lupus erythematosus, often causes cutaneous lupus, leading to rashes, hair loss, and skin scarring. These rashes result from immune-driven inflammation. Standard treatment ...
A groundbreaking study identifies key prenatal vitamins that may help reduce the risk of infant death, offering new insights into maternal and child health. New research identifies prenatal ...
Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science ...
Blackstone (NYSE: BX), the world’s largest alternative asset manager, is expanding its presence in the life sciences sector with a new multibillion-dollar fund dedicated to drug development. The firm ...
BELGRADE - Following a decision by President Aleksandar Vucic to pardon 13 people detained during protest blockades in the country, the Public Prosecutor's Office of Serbia will halt criminal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback